SIRT1 and neoplasm: Similarly, betulinic acid derivative (B10) increased FOXO3a transcription and reduced SIRT1 expression leading to induced apoptosis in vitro and reduced in vivo tumor growth and hence B10 is a novel therapeutic candidate for glioma treatment (Huo et al., 2017).